Use of composite scares in the quantification of deterioration in multiple sclerosis

被引：3

作者：

Lienert, C ^{[1
]}

Lechner-Scott, J ^{[1
]}

Schött, D ^{[1
]}

Constantinescu, C ^{[1
]}

Kappos, L ^{[1
]}

机构：

[1] Kantonsspital, Dept Neurol, Univ Hosp, CH-4031 Basel, Switzerland

来源：

MULTIPLE SCLEROSIS | 1999年 / 5卷 / 04期

关键词：

EDSS; clinical outcome assessment system;

D O I：

10.1191/135245899678846122

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：220 / 222

页数：3

共 8 条

[1] LOW-DOSE (7.5-MG) ORAL METHOTREXATE REDUCES THE RATE OF PROGRESSION IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].

GOODKIN, DE ;

RUDICK, RA ;

MEDENDORP, SV ;

DAUGHTRY, MM ;

SCHWETZ, KM ;

FISCHER, J ;

VANDYKE, C .

ANNALS OF NEUROLOGY, 1995, 37 (01) :30-40

[2]

KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444

[3]

PETKAU AJ, 1996, MULTIPLE SCLEROSIS A, P63

[4] Clinical outcomes assessment in multiple sclerosis [J].

Rudick, R ;

Antel, J ;

Confavreux, C ;

Cutter, G ;

Ellison, G ;

Fischer, J ;

Lublin, F ;

Miller, A ;

Petkau, J ;

Rao, S ;

Reingold, S ;

Syndulko, K ;

Thompson, A ;

Wallenberg, J ;

Weinshenker, B ;

Willoughby, E .

ANNALS OF NEUROLOGY, 1996, 40 (03) :469-479

[5] Recommendations from the national multiple sclerosis society clinical outcomes assessment task force [J].

Rudick, R ;

Antel, J ;

Confavreux, C ;

Cutter, G ;

Ellison, G ;

Fischer, J ;

Lublin, F ;

Miller, A ;

Petkau, J ;

Rao, S ;

Reingold, S ;

Syndulko, K ;

Thompson, A ;

Wallenberg, J ;

Weinshenker, B ;

Willoughby, E .

ANNALS OF NEUROLOGY, 1997, 42 (03) :379-382

[6] Clinical scales for multiple sclerosis [J].

Sharrack, B ;

Hughes, RAC .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 135 (01) :1-9

[7]

WEINSHENKER BG, 1996, MULTIPLE SCLEROSIS A, P105

[8]

Whitaker J N, 1995, Mult Scler, V1, P37

← 1 →